Results 341 to 350 of about 580,532 (393)
Some of the next articles are maybe not open access.

Single-nucleus profiling of human dilated and hypertrophic cardiomyopathy

Nature, 2022
Mark Chaffin   +2 more
exaly   +2 more sources

Dilated cardiomyopathy

Current Opinion in Cardiology, 1994
The etiology and pathogenesis of dilated cardiomyopathy continues to be controversial. The importance of viral and familial etiologies is becoming increasingly recognized. Molecular biology will add significantly to our understanding of these factors in the near future.
S C, Siu, M J, Sole
openaire   +2 more sources

Dilated cardiomyopathy

The Lancet, 2017
Dilated cardiomyopathy is defined by the presence of left ventricular dilatation and contractile dysfunction. Genetic mutations involving genes that encode cytoskeletal, sarcomere, and nuclear envelope proteins, among others, account for up to 35% of cases. Acquired causes include myocarditis and exposure to alcohol, drugs and toxins, and metabolic and
Robert G, Weintraub   +2 more
openaire   +2 more sources

Immunoadsorption in dilated cardiomyopathy

Transfusion and Apheresis Science, 2007
Dilated cardiomyopathy (DCM) is a common myocardial disease characterized by ventricular dilatation and progressive depression of myocardial contractile function. Disturbances in both humoral and cellular immunity have been described among these patients. A number of antibodies against various cardiac cell proteins have been identified in DCM.
Stephan B. Felix, Alexander Staudt
openaire   +3 more sources

Dilated cardiomyopathy

Current Treatment Options in Cardiovascular Medicine, 2001
The management of patients with dilated cardiomyopathy (DCM) heart failure starts with the determination of the underlying diagnosis, definition of the hemodynamic character (eg, systolic, diastolic, valvular, right- and left-sided heart dysfunction), recognition of complicating factors (eg, atrial fibrillation, renal dysfunction), and consideration ...
openaire   +3 more sources

Dilated cardiomyopathy

2018
Dilated cardiomyopathy (DCM) is a common cause of heart failure in the general population. In the past decade, the prognosis of DCM patients has improved significantly, thanks to advances in medical therapy and the introduction of device(s) treatment. Despite these advances, the 10-year survival remains <60%, with deaths often preceded by numerous ...
Masci, Pier Giorgio   +2 more
openaire   +2 more sources

Dilated cardiomyopathy

European Heart Journal, 1984
On account of the rapidly progressive nature of the disease, the high incidence of systemic embolism and arrhythmias, and the risk of sudden death, dilated cardiomyopathy is inconsistent with aircrew duties. In the small proportion of subjects who apparently make a satisfactory recovery , re-licensing may be considered once there is no requirement for ...
openaire   +2 more sources

Idiopathic Dilated Cardiomyopathy

New England Journal of Medicine, 1994
Idiopathic dilated cardiomyopathy (IDC) is a primary myocardial disease of unknown cause characterized by left ventricular or biventricular dilatation and impaired myocardial contractility1.
G W, Dec, V, Fuster
openaire   +4 more sources

Home - About - Disclaimer - Privacy